Second-site genetic modifiers of CTG/CAG microsatellite stability

CTG/CAG 微卫星稳定性的第二位点遗传修饰剂

• 批准号: 8870378
• 负责人: Michael LEFFAK
• 金额: $ 27.74万
• 依托单位: WRIGHT STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-05-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8870378
• 关键词: 3' Untranslated Regions; Affect; Age of Onset; Alleles; Biological Assay; Biological Models; C-terminal; CAG repeat; Candidate Disease Gene; Cell Culture System; Cell Line; Cells; Characteristics; Child; Chromatin; Clinical; Colon Carcinoma; Cultured Cells; Custom; DNA; DNA Damage; DNA Repair; DNA Sequence; DNA biosynthesis; DNA-Directed DNA Polymerase; Data; Dependence; Diagnosis; Disease; Environment; Family; Fluorescence; Gene Expression; Gene Family; Gene Targeting; Genes; Genetic; Genome; Genome Stability; Genomic Instability; Goals; Hela Cells; Human; Human Engineering; Huntington Disease; Individual; Inherited; Knock-in Mouse; Length; Libraries; Life; Link; Location; Metabolic; Metabolic Pathway; Metabolism; Microsatellite Instability; Microsatellite Repeats; Mismatch Repair; Modeling; Molecular; Monitor; Mosaicism; Muscular Dystrophies; Mutation; Myotonic Dystrophy; Neurodegenerative Disorders; Ontology; Organ; Other Genetics; Parents; Pathway interactions; Patients; Penetrance; Phenotype; Physicians; Plasmids; Proteins; RNA Interference; Recurrence; Replication Origin; Risk; Risk Factors; Severity of illness; Signal Transduction; Site; Skeletal Muscle; Symptoms; System; Technology; Testing; Time; Tissues; Transcript; Transfection; Treatment Protocols; Trinucleotide Repeats; Work; Zinc Fingers; base; c-myc Genes; chemotherapy; human embryonic stem cell; in vivo; insight; malignant breast neoplasm; nervous system disorder; nuclease; outcome forecast; prognostic value; screening; sensor; small hairpin RNA

DESCRIPTION (provided by applicant): Genomic instability of simple DNA sequence repeats (DNA microsatellites) is the cause of more than 30 human neurological diseases. In the case of myotonic dystrophy type 1 (DM1), an autosomal dominant disease of skeletal muscle with multiple phenotypes in other organs, the molecular trigger of disease is an increase in the number of CTG/CAG trinucleotide repeats in the 3' UTR of the DMPK gene. Dramatically increased CTG/CAG copy numbers can occur intergenerationally, or more modest expansions can occur somatically throughout life and differ substantially between tissues. The extent of CTG/CAG expansion is linked to increased disease severity and earlier age of onset of symptoms, but the penetrance of DM1 varies widely. This suggests that other genetic loci (second site genes) significantly affect the stability of CTG/CAG repeats in trans. The goal of this project is to characterize second site genes that contribute to CTG/CAG microsatellite instability. We will take a candidate gene approach to carry out the Aims of this work: (i) to identify genes required for the instability of DMPK (CTG/CAG) repeats by shRNA knockdown, small pool PCR and PAGE; (ii) to determine the effect of gene knockdown on the time course and length dependence of CTG/CAG instability, and effects on other disease-related microsatellites; (iii) to identify DNA hairpin pathways of CTG/CAG instability in vivo. The long term goals of this work are to understand the mechanistic basis for human CTG/CAG microsatellite instability in vivo, and the correlation of second site gene expression levels with DM1 phenotypes. We have engineered human cultured cells in which different lengths of DMPK CTG/CAG microsatellite repeat DNA have been inserted at a unique chromosomal location; this model assay system mimics the CTG/CAG instability observed in DM1 patient cells. Importantly, we have shown that knockdown of second site genes in DNA metabolic pathways promotes CTG/CAG repeat instability. The first result of this project will be the compilation of a list of genes whose expression levels could be used to predict CTG/CAG instability in a family, or in specific tissues of a patient. We will also perform molecular characterization of the effect of second site gene knockdown on the formation of unstable DNA hairpin intermediates in vivo, the rate of instability, the instability of pre-mutation CTG/CAG repeats, and the effects of these genetic modifiers on the stability of other microsatellites. The clinical value of these risk factors would include the prognosis of sporadic symptoms that are difficult to predict by periodic screening, and the individualization of treatment regimens. Similar tests of gene expression levels are currently in use by more than 7500 physicians and 90,000 patients to predict chemotherapy benefit and disease recurrence in breast and colon cancer. Our data generated thus far using this assay system as a sensor of DNA metabolism show that the identification of genes involved in CTG/CAG repeat instability will give insight into the basic mechanisms of genome stability and microsatellite expansion in multiple neurodegenerative disorders.

描述（由申请人提供）： 简单DNA序列重复序列（DNA微卫星）的基因组不稳定性是30多种人类神经系统疾病的原因。对于1型肌发育症（DM1），在其他器官中具有多种表型的骨骼肌的常染色体显性疾病，疾病的分子触发是CTG/CAG/CAG三核苷酸重复剂的数量增加。 CTG/CAG拷贝数急剧增加，可以在整个生命中发生在整个生命中，或者在组织之间存在显着差异。 CTG/CAG扩张的程度与疾病的严重程度增加和症状发作年龄的增长有关，但DM1的渗透率差异很大。这表明其他遗传基因座（第二个位点基因）显着影响反式转移中CTG/CAG重复的稳定性。该项目的目的是表征有助于CTG/CAG微卫星不稳定性的第二个位点基因。我们将采用一种候选基因方法来执行这项工作的目的：（i）确定shrna敲低，小池PCR和PAGE重复DMPK（CTG/CAG）重复不稳定性所需的基因； （ii）确定基因敲低对CTG/CAG不稳定性的时间过程和长度依赖性的影响，以及对其他与疾病相关的微卫星的影响； （iii）识别体内CTG/CAG不稳定性的DNA发夹途径。这项工作的长期目标是了解体内人类CTG/CAG微卫星不稳定性的机理基础，以及第二位点基因表达水平与DM1表型的相关性。我们已经设计了人类培养的细胞，其中将不同长度的DMPK CTG/CAG微卫星重复DNA插入了独特的染色体位置。该模型测定系统模仿DM1患者细胞中观察到的CTG/CAG不稳定性。重要的是，我们已经表明，DNA代谢途径中第二个位点基因的敲低会促进CTG/CAG重复不稳定性。该项目的第一个结果将是汇编的基因列表，其表达水平可用于预测家庭或患者特定组织中的CTG/CAG不稳定性。我们还将对第二位点基因敲低对体内不稳定的DNA脱发中间体形成的影响进行分子表征，不稳定速率，预先致命的CTG/CAG重复序列的不稳定性以及这些遗传修饰符对其他微膜质稳定性的影响。这些危险因素的临床价值将包括难以通过周期性筛查和治疗方案个性化来预测的零星症状的预后。目前，有7500多名医生和90,000名患者正在使用类似的基因表达水平测试，以预测乳腺癌和结肠癌中的化学疗法益处和疾病复发。迄今为止，我们使用该测定系统作为DNA代谢传感器生成的数据表明，鉴定CTG/CAG重复不稳定性所涉及的基因将深入了解多种神经退行性疾病中基因组稳定性和微磷灰石扩张的基本机制。